<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META content="text/html; charset=iso-8859-1" http-equiv=Content-Type>
<META name=GENERATOR content="MSHTML 9.00.8112.16447">
<STYLE></STYLE>
</HEAD>
<BODY bgColor=#ffffff>
<DIV><SPAN
style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: #111111; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"
lang=EN-US>See also this study :</SPAN></DIV>
<DIV><SPAN
style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: #111111; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"
lang=EN-US>BJÖRK, B.C. <I style="mso-bidi-font-style: normal">A Study of
Innovative Features in Scholarly Open Access Journals</I>. Journal of Medical
Internet Research, vol. 13 (4), 2011. <SPAN
style="mso-spacerun: yes"> </SPAN></SPAN><SPAN
style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 11pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: FR; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"><A
href="http://www.jmir.org/2011/4/e115/"><SPAN
style="LINE-HEIGHT: 115%; FONT-SIZE: 12pt; mso-ansi-language: EN-US"
lang=EN-US><FONT
color=#295c8e>http://www.jmir.org/2011/4/e115/</FONT></SPAN></A></SPAN><SPAN
style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"
lang=EN-US> </SPAN></DIV>
<DIV><SPAN
style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"
lang=EN-US></SPAN> </DIV>
<DIV><SPAN
style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"
lang=EN-US><FONT color=#111111>Hélène Bosc</FONT></SPAN></DIV>
<DIV><SPAN
style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"
lang=EN-US><FONT color=#111111>Open access to Scientific
Communication </FONT></SPAN></DIV>
<DIV><SPAN
style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"
lang=EN-US><FONT color=#111111><A
href="http://open-access.infodocs.eu/tiki-index.php">http://open-access.infodocs.eu/tiki-index.php</A></FONT></SPAN></DIV>
<BLOCKQUOTE
style="BORDER-LEFT: #000000 2px solid; PADDING-LEFT: 5px; PADDING-RIGHT: 0px; MARGIN-LEFT: 5px; MARGIN-RIGHT: 0px">
<DIV style="FONT: 10pt arial">----- Original Message ----- </DIV>
<DIV
style="FONT: 10pt arial; BACKGROUND: #e4e4e4; font-color: black"><B>From:</B>
<A title=peter.suber@gmail.com href="mailto:peter.suber@gmail.com">Peter
Suber</A> </DIV>
<DIV style="FONT: 10pt arial"><B>To:</B> <A title=goal@eprints.org
href="mailto:goal@eprints.org">Global Open Access List (Successor of
AmSci)</A> </DIV>
<DIV style="FONT: 10pt arial"><B>Sent:</B> Thursday, July 19, 2012 3:01
PM</DIV>
<DIV style="FONT: 10pt arial"><B>Subject:</B> [GOAL] Re: Finding a business
model for a growing Open AccessJournal</DIV>
<DIV><BR></DIV><FONT size=+0><FONT face="trebuchet ms,sans-serif">See the list
of OA journal business models at the Open Access Directory.</FONT></FONT>
<DIV><FONT size=+0><FONT face="trebuchet ms,sans-serif"><A
href="http://oad.simmons.edu/oadwiki/OA_journal_business_models">http://oad.simmons.edu/oadwiki/OA_journal_business_models</A></FONT></FONT></DIV>
<DIV><FONT size=+0><FONT
face="trebuchet ms,sans-serif"><BR></FONT></FONT></DIV>
<DIV><SPAN style="FONT-FAMILY: 'trebuchet ms',sans-serif">
Peter </SPAN></DIV>
<DIV><SPAN style="FONT-FAMILY: 'trebuchet ms',sans-serif"><BR></SPAN></DIV>
<DIV><FONT face="trebuchet ms, sans-serif">Peter Suber</FONT></DIV>
<DIV><FONT face="trebuchet ms, sans-serif"><A
href="http://gplus.to/petersuber">gplus.to/petersuber</A> </FONT></DIV>
<DIV><FONT size=+0><FONT face="trebuchet ms,sans-serif"><BR></FONT></FONT><BR>
<DIV class=gmail_quote>On Thu, Jul 19, 2012 at 8:17 AM, Peter Murray-Rust
<SPAN dir=ltr><<A href="mailto:pm286@cam.ac.uk"
target=_blank>pm286@cam.ac.uk</A>></SPAN> wrote:<BR>
<BLOCKQUOTE
style="BORDER-LEFT: #ccc 1px solid; MARGIN: 0px 0px 0px 0.8ex; PADDING-LEFT: 1ex"
class=gmail_quote>I am forwarding a message from the OKFN's open-access list
(<A href="http://lists.okfn.org/mailman/listinfo/open-access"
target=_blank>http://lists.okfn.org/mailman/listinfo/open-access</A> which
uses the term strictly to mean BOAI-compliant).<BR><BR>The poster Katie runs
a successful OA journal and asks how she can scale up without APCs. She
raises the idea of a SCOAP3-like model for cancer. There must be a number of
other people with the same question:<BR>* they don't want closed access<BR>*
they don't want author-side fees<BR>* they recognize the money has to come
from somewhere.<BR><BR>Katie (and I) would be interested to know of possible
models and possible nuclei of like-minded groups.<BR><BR>This seems to me
one of the key problems of the current time of transition.<BR><BR>
<DIV class=gmail_quote>---------- Forwarded message ----------<BR>From: <B
class=gmail_sendername>Katie Foxall</B> <SPAN dir=ltr><<A
href="mailto:katie@ecancer.org"
target=_blank>katie@ecancer.org</A>></SPAN><BR>Date: Thu, Jul 19, 2012 at
10:53 AM<BR>Subject: Re: [Open-access] SCOAP3<BR>To: <A
href="mailto:open-access@lists.okfn.org"
target=_blank>open-access@lists.okfn.org</A><BR><BR><BR>Hello all<BR><BR>I
haven't posted [on OKFN open-access] before but have been following the
discussions with much<BR>interest and have founds the info and links
provided by various people<BR>really useful. I run an open access
cancer journal <A href="http://ecancer.org/ecms"
target=_blank>http://ecancer.org/ecms</A><BR>which has no author fees - we
are currently mainly supported by charity<BR>funding but the journal has
been growing at a great rate this year so I'm<BR>looking into accessing any
funding that might be out there to support open<BR>access publishing.
The reality is that we will have to start charging<BR>author fees at
some point if we can't get more funding and we really don't<BR>want to do
that as providing a free service for the oncology community is<BR>very
important to us.<BR><BR>So does anyone know whether there is anything like
SCOAP3 in the field of<BR>medical publishing?<BR><BR>Thanks in advance for
any help or advice anyone might be able to give me,<BR><BR>Katie Foxall<BR>
<DIV>
<DIV><BR>-----Original Message-----<BR>From: <A
href="mailto:open-access-bounces@lists.okfn.org"
target=_blank>open-access-bounces@lists.okfn.org</A><BR>[mailto:<A
href="mailto:open-access-bounces@lists.okfn.org"
target=_blank>open-access-bounces@lists.okfn.org</A>] On Behalf Of<BR><A
href="mailto:cn@cameronneylon.net"
target=_blank>cn@cameronneylon.net</A><BR>Sent: 18 July 2012 15:50<BR>To: <A
href="mailto:open-access@lists.okfn.org"
target=_blank>open-access@lists.okfn.org</A><BR>Subject: [Open-access]
SCOAP3<BR><BR>Not got so much press as the big announcements this week but
this is a big<BR>deal. Communities can just decide unilaterally to move to
OA.<BR><BR><A href="http://scoap3.org/news/news94.html"
target=_blank>http://scoap3.org/news/news94.html</A><BR>_______________________________________________<BR>open-access
mailing list<BR><A href="mailto:open-access@lists.okfn.org"
target=_blank>open-access@lists.okfn.org</A><BR><A
href="http://lists.okfn.org/mailman/listinfo/open-access"
target=_blank>http://lists.okfn.org/mailman/listinfo/open-access</A><BR><BR><BR>_______________________________________________<BR>open-access
mailing list<BR><A href="mailto:open-access@lists.okfn.org"
target=_blank>open-access@lists.okfn.org</A><BR><A
href="http://lists.okfn.org/mailman/listinfo/open-access"
target=_blank>http://lists.okfn.org/mailman/listinfo/open-access</A><SPAN
class=HOEnZb><FONT color=#888888><BR></FONT></SPAN></DIV></DIV></DIV><SPAN
class=HOEnZb><FONT color=#888888><BR><BR clear=all><BR>-- <BR>Peter
Murray-Rust<BR>Reader in Molecular Informatics<BR>Unilever Centre, Dep. Of
Chemistry<BR>University of Cambridge<BR>CB2 1EW, UK<BR><A
href="tel:%2B44-1223-763069" target=_blank
value="+441223763069">+44-1223-763069</A><BR></FONT></SPAN><BR>_______________________________________________<BR>GOAL
mailing list<BR><A href="mailto:GOAL@eprints.org">GOAL@eprints.org</A><BR><A
href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal"
target=_blank>http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</A><BR><BR></BLOCKQUOTE></DIV><BR></DIV>
<P>
<HR>
<P></P>_______________________________________________<BR>GOAL mailing
list<BR>GOAL@eprints.org<BR>http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal<BR></BLOCKQUOTE></BODY></HTML>